These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 21115979)
41. The genetic landscape of histologically transformed marginal zone lymphomas. Li A; Yi H; Deng S; Ruan M; Xu P; Huo Y; Lu H; Shen X; Ouyang B; Cai M; Xu H; Wang Z; Zhang L; Zhu L; Peng Q; Gu Y; Xie J; Wang Y; Dong L; Liu Z; Wang C Cancer; 2024 Apr; 130(8):1246-1256. PubMed ID: 37941429 [TBL] [Abstract][Full Text] [Related]
42. Marginal zone B-cell lymphomas (MZBL) arising at different sites represent different biological entities. Ott MM; Rosenwald A; Katzenberger T; Dreyling M; Krumdiek AK; Kalla J; Greiner A; Ott G; Müller-Hermelink HK Genes Chromosomes Cancer; 2000 Aug; 28(4):380-6. PubMed ID: 10862046 [TBL] [Abstract][Full Text] [Related]
43. Primary nodal marginal zone lymphomas of splenic and MALT type. Nathwani BN; Drachenberg MR; Hernandez AM Am J Surg Pathol; 2000 Feb; 24(2):317-9. PubMed ID: 10680907 [No Abstract] [Full Text] [Related]
44. Bone marrow involvement by marginal zone B-cell lymphomas of different types. Inamdar KV; Medeiros LJ; Jorgensen JL; Amin HM; Schlette EJ Am J Clin Pathol; 2008 May; 129(5):714-22. PubMed ID: 18426730 [TBL] [Abstract][Full Text] [Related]
45. Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Remstein ED; James CD; Kurtin PJ Am J Pathol; 2000 Apr; 156(4):1183-8. PubMed ID: 10751343 [TBL] [Abstract][Full Text] [Related]
46. Immunogenetics features and genomic lesions in splenic marginal zone lymphoma. Rinaldi A; Forconi F; Arcaini L; Mian M; Sozzi E; Zibellini S; Baldini L; Franceschetti S; Gaidano G; Marasca R; Mollejo M; Piris MA; Tucci A; Facchetti F; Bhagat G; Favera RD; Rancoita PM; Zucca E; Kwee I; Bertoni F Br J Haematol; 2010 Dec; 151(5):435-9. PubMed ID: 21113978 [TBL] [Abstract][Full Text] [Related]
47. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030 [TBL] [Abstract][Full Text] [Related]
48. DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features. Arribas AJ; Rinaldi A; Mensah AA; Kwee I; Cascione L; Robles EF; Martinez-Climent JA; Oscier D; Arcaini L; Baldini L; Marasca R; Thieblemont C; Briere J; Forconi F; Zamò A; Bonifacio M; Mollejo M; Facchetti F; Dirnhofer S; Ponzoni M; Bhagat G; Piris MA; Gaidano G; Zucca E; Rossi D; Bertoni F Blood; 2015 Mar; 125(12):1922-31. PubMed ID: 25612624 [TBL] [Abstract][Full Text] [Related]
49. Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Rosenwald A; Ott G; Stilgenbauer S; Kalla J; Bredt M; Katzenberger T; Greiner A; Ott MM; Gawin B; Döhner H; Müller-Hermelink HK Am J Pathol; 1999 Dec; 155(6):1817-21. PubMed ID: 10595910 [TBL] [Abstract][Full Text] [Related]
50. Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas. Bertoni F; Conconi A; Luminari S; Realini C; Roggero E; Baldini L; Carobbio S; Cavalli F; Neri A; Zucca E Leukemia; 2000 Mar; 14(3):446-8. PubMed ID: 10720140 [TBL] [Abstract][Full Text] [Related]
51. A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands. Chanudet E; Ye H; Ferry J; Bacon CM; Adam P; Müller-Hermelink HK; Radford J; Pileri SA; Ichimura K; Collins VP; Hamoudi RA; Nicholson AG; Wotherspoon AC; Isaacson PG; Du MQ J Pathol; 2009 Feb; 217(3):420-30. PubMed ID: 19006194 [TBL] [Abstract][Full Text] [Related]
52. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation. Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947 [TBL] [Abstract][Full Text] [Related]
53. Histologic transformation in marginal zone lymphomas†. Conconi A; Franceschetti S; Aprile von Hohenstaufen K; Margiotta-Casaluci G; Stathis A; Moccia AA; Bertoni F; Ramponi A; Mazzucchelli L; Cavalli F; Gaidano G; Zucca E Ann Oncol; 2015 Nov; 26(11):2329-35. PubMed ID: 26400898 [TBL] [Abstract][Full Text] [Related]
54. Marginal zone lymphomas: management of nodal, splenic, and MALT NHL. Kahl B; Yang D Hematology Am Soc Hematol Educ Program; 2008; ():359-64. PubMed ID: 19074110 [TBL] [Abstract][Full Text] [Related]
55. Follicular lymphoma and marginal zone lymphoma: how many diseases? Laurent C; Cook JR; Yoshino T; Quintanilla-Martinez L; Jaffe ES Virchows Arch; 2023 Jan; 482(1):149-162. PubMed ID: 36394631 [TBL] [Abstract][Full Text] [Related]
56. Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling. Arribas AJ; Gómez-Abad C; Sánchez-Beato M; Martinez N; Dilisio L; Casado F; Cruz MA; Algara P; Piris MA; Mollejo M Mod Pathol; 2013 Jul; 26(7):889-901. PubMed ID: 23429603 [TBL] [Abstract][Full Text] [Related]
57. Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q. Solé F; Salido M; Espinet B; Garcia JL; Martinez Climent JA; Granada I; Hernández JM; Benet I; Piris MA; Mollejo M; Martinez P; Vallespí T; Domingo A; Serrano S; Woessner S; Florensa L Haematologica; 2001 Jan; 86(1):71-7. PubMed ID: 11146574 [TBL] [Abstract][Full Text] [Related]
58. Splenic marginal zone lymphomas of mice. Fredrickson TN; Lennert K; Chattopadhyay SK; Morse HC; Hartley JW Am J Pathol; 1999 Mar; 154(3):805-12. PubMed ID: 10079258 [TBL] [Abstract][Full Text] [Related]